89 results
8-K
EX-99.2
PHASQ
PhaseBio Pharmaceuticals Inc
12 Mar 24
Entry into a Material Definitive Agreement
4:34pm
Liability
Long Term Portion of JMB Debt
Long Term Operating Lease Liability
Long Term Portion of Deferred Sublicense Revenue
Development Derivative
Total
8-K
EX-99.3
PHASQ
PhaseBio Pharmaceuticals Inc
12 Mar 24
Entry into a Material Definitive Agreement
4:34pm
Interest
Short Term Operating Lease Liability
Long Term Portion of JMB Debt
Long Term Operating Lease Liability
Long Term Portion of Deferred Sublicense
8-K
EX-99.1
PHASQ
PhaseBio Pharmaceuticals Inc
12 Mar 24
Entry into a Material Definitive Agreement
4:34pm
of Deferred Sublicense Revenue
Accrued Clinical and MFG, and Other
Accrued Interest
Short Term Operating Lease Liability
Long Term Portion of JMB … Debt
Long Term Operating Lease Liability
Long Term Portion of Deferred Sublicense Revenue
Development Derivative
Total Liabilities
Common Stock
APIC
8-K
EX-99.2
PHASQ
PhaseBio Pharmaceuticals Inc
29 Nov 23
Other Events
4:55pm
- Long Term Portion of JMB Debt - Long Term Operating Lease Liability - Long Term Portion of Deferred Sublicense Revenue - Development Derivative - Total
8-K
EX-99.1
PHASQ
PhaseBio Pharmaceuticals Inc
29 Nov 23
Other Events
4:55pm
, and Other 5,987,156 Accrued Interest - Short Term Operating Lease Liability - Long Term Portion of JMB Debt - Long Term Operating Lease Liability - Long … Term Portion of Deferred Sublicense Revenue - Development Derivative - Total Liabilities 42,612,515 Common Stock 50,175 APIC - Common Stock
8-K
EX-99.1
m3lv6
27 Sep 23
Other Events
8:52am
8-K
EX-99.1
qin5r03rlrzw
25 Aug 23
Other Events
12:34pm
8-K
EX-99.2
ucee6is3
25 Aug 23
Other Events
12:34pm
8-K
EX-99.1
kbcmvp
30 Jun 23
Other Events
4:21pm
8-K
EX-99.1
hf7aad 8ku
30 May 23
Other Events
4:02pm
8-K
EX-99.1
5do cns7jbky24
10 May 23
Other Events
8:08am
8-K
EX-99.1
tqv2wd46sz1j171xa
23 Dec 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:33am
8-K
EX-99.1
3zc czqeqkopr0wvf0wm
23 Nov 22
Departure of Directors or Certain Officers
4:08pm
8-K
EX-99.2
1hqlitbn h6rnsijesp
12 Aug 22
PhaseBio Pharmaceuticals Reports Second Quarter 2022 Financial Results and Recent Business Highlights
8:32am
8-K
EX-99.1
c2k38kyea 10bu4aju
12 Aug 22
PhaseBio Pharmaceuticals Reports Second Quarter 2022 Financial Results and Recent Business Highlights
8:32am
8-K
EX-99.1
bpuocrjg0 7vrzngj3w
16 May 22
PhaseBio Pharmaceuticals Reports First Quarter 2022 Financial Results and Recent Business Highlights
12:00am
8-K
EX-99.2
r1362v3 33n
16 May 22
PhaseBio Pharmaceuticals Reports First Quarter 2022 Financial Results and Recent Business Highlights
12:00am